AZ, Accent to develop therapies targeting RNA-modifying proteins
These proteins control various aspects of RNA biology and represent a new target for cancer treatment
Read More
Tag: RNA-modifying proteins
- Tozorakimab shows significant benefit in two major COPD trials
- Daratumumab becomes first oncology injectable approved for patient administration
- Laigo Bio completes final close of €17m seed financing round
- Axplora announces expansion as newest part of $60m API investment programme
- DNA Script signs SYNTAX distribution agreements with Gencell, BMS and Biostream
